Sales and Marketing

Showing 15 posts of 11464 posts found.

Strong sales of Basilea’s Cresemba triggers second sales milestone payment from Pfizer

February 7, 2023 Sales and Marketing

Swiss commercial-stage biopharmaceutical company Basilea Pharmaceutica Ltd has announced that continued high sales of its drug Cresemba (isavuconazole) in China …

Tadashi Maruno

February 2, 2023 Sales and Marketing

  Hamamatsu Photonics Announces Mr. Tadashi Maruno as Representative Director and PresidentHamamatsu Photonics, a leading provider of cutting-edge photonics technology, …

Joydeep Goswami

February 2, 2023 Sales and Marketing

Illumina Appoints Joydeep Goswami Chief Financial Officer

COVID-19 treatments drive Pfizer’s annual earnings up to $100bn

February 1, 2023 Sales and Marketing

Big Pharma giant Pfizer’s annual earnings in 2022 reached $100bn, a considerable proportion of which came from its COVID-19 vaccine …

Novo Nordisk accused of violating FDA’s Fair Balance advertising policy

January 24, 2023 Sales and Marketing

Advocacy group, the Physicians Committee for Responsible Medicine, has accused Novo Nordisk of breaching FDA’s Fair Balance policy after Novo …

AstraZeneca set to buy CinCor for $1.8bn

January 9, 2023 Sales and Marketing

AstraZeneca has announced that it is set to acquire the clinical-stage biopharmaceutical company CinCor in a deal worth up to …

Moderna agrees first acquisition for $85m

January 6, 2023 Sales and Marketing

After a pivotal few years, Moderna has agreed its first acquisition, worth $85m, which will allow the company access to …

Cost of over 350 drugs expected to increase in 2023

January 3, 2023 Sales and Marketing

With many pharma companies preparing for President Joe Biden’s Inflation Reduction Act (IRA) to begin having an impact, and inflation …

Amgen expected to buy Horizon at valuation of $26bn

December 12, 2022 Sales and Marketing

Amgen Inc is expected to acquire biotech firm Horizon Therapeutics Plc at a valuation of $26bn. This would be Amgen’s …

Novartis and MorphoSys sign $23m deal

December 8, 2022 Sales and Marketing

MorphoSys has announced that it will sell its worldwide licensing rights to its preclinical cancer programme to Novartis in exchange …

AbbVie to enter deal with HotSpot for up to $335m

December 7, 2022 Sales and Marketing

AbbVie and HotSpot Therapeutics have begun working on a licensing option deal for HotSpot’s preclinical small-molecule allosteric therapy, which will …

EMA accepts marketing authorisation application for ALS treatment, tofersen

December 7, 2022 Sales and Marketing

The European Medicines Agency (EMA) has accepted a marketing authorisation application (MAA) for tofersen. The drug would treat superoxide dismutase …

AstraZeneca to acquire Neogene for up to $320m

November 29, 2022 Sales and Marketing

AstraZeneca has announced that it is planning to buy Neogene for up to $320m. Biotechnology group Neogene has a focus …

Full-Life Technologies to acquire Focus-X Therapeutics

November 29, 2022 Sales and Marketing

Full-Life Technologies, a fully integrated global radiotherapeutics company, has announced that they have agreed to acquire US-based Focus-X Therapeutics.  

Siemens Healthineers and Atrium Health team up in $140m deal

November 29, 2022 Sales and Marketing

Atrium Health, a US-based non-profit health provider, has signed a partnership with Siemens Healthineers to buy $140m worth of healthcare …

Latest content